<img alt="" src="https://secure.lazy8krti.com/218831.png" style="display:none;">

Living with Ankylosing Spondylitis (AS)

Published May 2022, US report

"Living with Ankylosing Spondylitis" is a syndicated patient report which offers low-cost, high-value quantitative insight into patient attitudes and behaviour.

We recognise pharma brands need access to unique insights if they are to develop effective products and treatments and relevant communications messages. Living with AS is designed to provide an in-depth understanding of the AS disease patient journey, from diagnosis through treatment and ongoing management, unveiling patients attitudes, needs and treatment programmes.

Gain an in-depth understanding of:

  • The diagnosis pathway from the perspective of patients
  • Patient attitudes to their condition and the impact on their lives
  • Treatments taken and satisfaction levels
  • Attitudes and behaviors with regard to switching and adherence
  • Attitudes to interactions with healthcare professionals, and presentation history
  • What patients are currently doing to cope with their condition
  • Patient wishes and unmet needs
  • Patients’ sources of information and use of digital tools, such as apps and social media


Living with AS US


Quant: 30-minute online interviews with AS patients on advanced and non-advanced treatments 
Qual: 40-minute qualitative telephone interviews with AS patients, including patient diary task 5 days before the interview

Countries US



Sample considerations
  • All patients were required to be diagnosed with AS (ankylosing spondylitis) by a doctor
  • Patients were categorized as either receiving advanced treatment (e.g. biologics, biosimilars) or non-advanced treatment (e.g. csDMARDs, NSAIDs)
  • Quotas were set to recruit specific numbers of patients on different therapy categories
  • Gender quota: female 53%, male 48%
  • Age quota: 18-29 yrs. 5%, 30-64 yrs. 85%, 65+ yrs. 10%


Request more information on Living With


Mariel Metcalfe

Director, Head of Living With

Mariel is the Head of Living With and has 18 years of pharmaceutical market research experience in a wide variety of qualitative and quantitative methodologies, including global tracker research and segmentation. She has worked in a variety of therapy areas including infectious, autoimmune, respiratory and metabolic diseases. Mariel has extensive experience in patient insights and is committed to bringing the patient voice to life. She has written multiple articles and hosts the podcast ‘Living with Chronic Illness’ which is designed to give a voice to patients suffering from chronic conditions.